As of June 21, 2025, Oxford Immunotec Global PLC (OXFD) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Oxford Immunotec Global PLC's Forward P/E to Peers
To better understand Oxford Immunotec Global PLC's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Oxford Immunotec Global PLC (OXFD) | - |
| EKF Diagnostics Holdings PLC (EKF.L) | 1752.90 |
| Smith & Nephew PLC (SN.L) | 1402.50 |
| Hamilton Thorne Ltd (HTL.V) | 352.94 |
| AxoGen Inc (AXGN) | 43.29 |
| Intricon Corp (IIN) | 41.38 |
Compared to its competitors, Oxford Immunotec Global PLC's Forward P/E is difficult to compare due to insufficient data.